Get started
CASSAVA SCIENCES, INCCASSAVA SCIENCES, INCCASSAVA SCIENCES, INC

CASSAVA SCIENCES, INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Forecast Seasonals

SAVA trade ideas

Stock Of The Day / 03.25.25 / SAVA03.25.2025 / NASDAQ:SAVA #SAVA Fundamentals. Closing the development of a drug for the treatment of Alzheimer's after another unsuccessful trial. Technical analysis. Daily chart: 4-month sideways movement after a downtrend. We makr the low of the sideways movement - 2.23 Premarket: Gap Down on moderate volume. Trading session: There is a struggle for the level of 2.23. in the premarket and after the opening of the trading session. The price gets into a narrow trading range below the level of 2.23 after 2 unsuccessful attempts to hold above the level. We are considering a short trade if the level is held. Trading scenario: #rebound from the level of 2.23 Entry: 2.18 when exit down from the trading range below the level Stop: 2.24, we hide it behind the level Exit: Close part of the position near the premarket low of 2.01. Close the rest of the position at 1.87 when volumes increase and a reversal candlestick pattern appears. Risk Rewards: 1/4 P.S. In order to understand the idea of the Stock Of The Day analysis, please read the following information .
NASDAQ:SAVAShort
by AlexX31
$SAVA Cassava Sciences Inc Long term PT 145 and higherNASDAQ:SAVA Cassava Sciences Inc Long term PT 145 and higher Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
NASDAQ:SAVALong
by BADQOMOCAWGOWLD
Sava Made a YouTube video on this yeateday Came to conclusion of a potential sick trade If we can start holding 35.50 as support (best option could be a breakout of 36.55 ) We have huge support at 33$ and 32.45. Anything below 32.45 could cancel the bullish veiw Looks to be a symtrical triangle with the downtrendinf upper reistance lining up with all of the highs along the downtrend. This is making a big fallinfnwedge potentially and we are also sitting at the weekly 21ema at 35.50 so the choice for bulls and the bears is, are we just rallying to the 21 weekly for a monster rejection, or are we going to pop up through this and rocket? Biggest next reistance above for me is 43$ even. This sets us up for a 18% gain potential from a 36.50 entry up to 43$. And a 30% upside gain from a 33$ entry. Risking above 2% down to 33 or 32.45 Risk to reward seems good just the entry level will be hard to get in as we are at a very clear reistance No daily candle body has closed above 35.50 yet so it gives us a VERY clear level! Take your bets, use your risk! I’ll be watching today and potentially taking a trade but patience will be huge in this! Remebe it has popped up above 35.50 just hasn’t ended the day above and opens the following day above so we have to keep that in mind! Good luck!!
NASDAQ:SAVALong
by Erictaylor
11
Swing trading on SAVA - 17-10-2022Hello everyone, 🌟 Here again Romluck with a new trading idea, The trading ideas I find are after searching and investing time. Thanks for the like and comment. "Cassava Sciences" : NASDAQ:SAVA Market Cap 1.55B Short Float 28.49%⛔️ Target Price 50$💰 What i see :👀 🔆triggering a possible buy near $40.28. 🔅place to put a stop loss is, near $32.98. 🔆Based on the entry and stop-loss, the estimated risk for the trade is $7.3 per share ($40.28 - $32.98). ⚠️__🚧___🚧___🚧__🚧___🚧__🚧_🚧__🚧__🚧__🚧__🚧_🚧__🚧__🚧_🚧__🚧_⚠️ There is no recommendation for buying or selling or any action in the stock, I am not an investment advisor and publish this article as a hobby only. Everyone has to perform risk management on their own or contact an investment advisor with a license, I don't have one. Investing in the stock market involves risking your money!⛔️ have fun
NASDAQ:SAVALong
by ROMLUCK
2
Cassava Sciences losing momentum. SAVAWe are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
NASDAQ:SAVAShort
by Rykin_Capital
2
Sava Ready to Plunge? Cassava Sciences Short Term - We look to Sell at 32.45 (stop at 36.81) We look to sell rallies. Trading volume is increasing. Previous support, now becomes resistance at 32.00. We can see no technical reason for a change of trend. The bias is still for lower levels and we look for any gains to be limited. Our profit targets will be 12.45 and 7.56 Resistance: 32.00 / 40.00 / 60.00 Support: 23.00 / 11.00 / 5.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:SAVAShort
by Saxo